Ultima-Adiptode (FTTP) 2mg Ultima Peptides

£50.00

Ultima-Adiptode (FTTP) 2mg represents a research-grade adiponectin receptor agonist from Ultima Peptides, available for in-vitro laboratory studies investigating metabolic signaling pathways and adipose tissue modulation.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Ultima-Adiptode (FTTP) 2mg Ultima Peptides
Ultima-Adiptode (FTTP) 2mg Ultima Peptides
£50.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Compound Profile: Ultima-Adiptode (FTTP)

Ultima-Adiptode (FTTP) 2mg is a specialized adiponectin receptor targeting compound developed by Ultima Peptides for advanced metabolic research applications. This research chemical belongs to the class of adiponectin receptor modulators, designed to investigate the complex signaling pathways involved in glucose homeostasis and lipid metabolism. Researchers at Stroid UK Shop can study this compound’s interactions with AdipoR1 and AdipoR2 receptors in controlled laboratory environments. The 2mg formulation provides precise dosing capabilities for experimental protocols examining adiponectin pathway activation and downstream metabolic effects in cellular models.

Laboratory Applications

Research scientists utilize Ultima-Adiptode to examine adiponectin signaling mechanisms in various experimental contexts. Studies focus on investigating AMPK pathway activation, fatty acid oxidation processes, and glucose uptake mechanisms in isolated cell cultures. The compound enables researchers to evaluate metabolic flux changes and mitochondrial biogenesis responses under controlled conditions. Comparative studies with other peptides demonstrate unique receptor binding characteristics and tissue-specific responses. Laboratory protocols frequently incorporate this compound alongside established metabolic modulators to study synergistic pathway interactions and cellular energy balance mechanisms.

Technical Specifications

Ultima-Adiptode (FTTP) 2mg Research Specifications
Parameter Value
Active Content 2mg per vial
Manufacturer Ultima Peptides
Formulation Lyophilized powder
Storage Requirements -20°C (lyophilized), 2-8°C (reconstituted)
Stability 36 months sealed, 30 days reconstituted
Solubility Water soluble
CAS Number Verify with supplier
Molecular Formula Verify with supplier

Research facilities studying metabolic pathways often combine this compound with investigations into SARMs to examine comprehensive anabolic-metabolic interactions in experimental models.

Regulatory Compliance

Ultima-Adiptode (FTTP) 2mg is supplied exclusively for in-vitro research purposes and is not intended for human consumption, therapeutic use, or clinical applications. This research chemical must be handled by qualified laboratory personnel in appropriate research facilities following institutional safety protocols. Researchers should maintain proper documentation of experimental procedures and storage conditions. All studies involving this compound must comply with relevant research institution guidelines and local regulations governing research chemical use.

Related